Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
| Aktionär | Typ | Gehalten (Tatsächlich) | % Ausstehender Aktien | Marktwert | Positionsdatum |
|---|---|---|---|---|---|
| OrbiMed Advisors LLC | Institution | 19.404.757 | 19,29% | US$ 79,17M | 2026-04-24 |
| OrbiMed Private Investments VI, LP | Institution | 17.405.831 | 17,31% | US$ 71,02M | 2026-04-24 |
| Baker Bros. Advisors LP | Institution | 17.293.897 | 17,19% | US$ 70,56M | 2026-04-21 |
| Baker Brothers Life Sciences, L.P. | Institution | 15.787.178 | 15,70% | US$ 64,41M | 2026-04-21 |
| RA Capital Management, L.P. | Institution | 6.475.882 | 6,44% | US$ 26,42M | 2026-04-27 |
| RA Capital Healthcare Fund, L.P. | Institution | 6.475.882 | 6,44% | US$ 26,42M | 2026-04-27 |
| Incyte Corporation | Institution | 4.372.124 | 4,35% | US$ 17,84M | 2025-11-03 |
| Dr. Krishna Vaddi | Insider | 3.117.278 | 3,10% | US$ 12,72M | 2025-12-31 |
| Kynam Capital Management, LP | Institution | 1.592.551 | 1,58% | US$ 6,50M | 2026-03-31 |
| 667, L.P. | Institution | 1.501.531 | 1,49% | US$ 6,13M | 2026-04-21 |
| Vanguard Capital Management, LLC | Institution | 1.230.406 | 1,22% | US$ 5,02M | 2026-03-31 |
| OrbiMed Genesis Master Fund, L.P. | Institution | 1.126.126 | 1,12% | US$ 4,59M | 2026-04-24 |
| EcoR1 Capital, LLC | Institution | 947.049 | 0,94% | US$ 3,86M | 2026-03-31 |
| Two Sigma Investments, LP | Institution | 923.626 | 0,92% | US$ 3,77M | 2026-03-31 |
| Sphera Funds Management Ltd | Institution | 558.339 | 0,56% | US$ 2,28M | 2026-03-31 |
| Blue Sky Trust | Institution | 551.776 | 0,55% | US$ 2,25M | 2025-12-31 |
| OrbiMed Partners Master Fund Limited | Institution | 526.300 | 0,52% | US$ 2,15M | 2026-04-24 |
| Acadian Asset Management LLC | Institution | 511.519 | 0,51% | US$ 2,09M | 2026-03-31 |
| Dr. Paul Friedman | Insider | 500.098 | 0,50% | US$ 2,04M | 2025-03-31 |
| Dr. Andrew Combs | Insider | 480.123 | 0,48% | US$ 1,96M | 2025-03-31 |
| Millennium Management LLC | Institution | 382.737 | 0,38% | US$ 1,56M | 2026-03-31 |
| Marshall Wace LLP | Institution | 358.906 | 0,36% | US$ 1,46M | 2026-03-31 |
| Morgan Stanley | Institution | 322.161 | 0,32% | US$ 1,31M | 2026-03-31 |
| BlackRock, Inc. | Institution | 321.886 | 0,32% | US$ 1,31M | 2026-03-31 |
| Geode Capital Management, LLC | Institution | 302.458 | 0,30% | US$ 1,23M | 2026-03-31 |
| Renaissance Technologies LLC | Institution | 275.200 | 0,27% | US$ 1,12M | 2026-03-31 |
| Susquehanna International Group, LLP | Institution | 267.788 | 0,27% | US$ 1,09M | 2026-03-31 |
| The Goldman Sachs Group, Inc. | Institution | 236.469 | 0,24% | US$ 964,79k | 2026-03-31 |
| Jane Street Group, LLC | Institution | 192.963 | 0,19% | US$ 787,29k | 2026-03-31 |
| Dr. Peggy Scherle | Insider | 185.685 | 0,18% | US$ 757,59k | 2025-03-31 |
| Vanguard Fiduciary Trust Company | Institution | 157.380 | 0,16% | US$ 642,11k | 2026-03-31 |
| ADAR1 Capital Management, LLC | Institution | 152.825 | 0,15% | US$ 623,53k | 2026-03-31 |
| State Street Global Advisors, Inc. | Institution | 138.231 | 0,14% | US$ 563,98k | 2026-03-31 |
| Citadel Advisors LLC | Institution | 124.378 | 0,12% | US$ 507,46k | 2026-03-31 |
| Connor, Clark & Lunn Investment Management Ltd. | Institution | 109.085 | 0,11% | US$ 445,07k | 2026-03-31 |
| Mr. Sean Brusky | Insider | 100.000 | 0,10% | US$ 408,00k | 2026-03-05 |
| SEI Investments Company | Institution | 95.100 | 0,09% | US$ 388,01k | 2026-04-30 |
| Dr. Edna Huang | Insider | 86.917 | 0,09% | US$ 354,62k | 2025-10-04 |
| UBS Asset Management AG | Institution | 64.505 | 0,06% | US$ 263,18k | 2026-03-31 |
| Hudson River Trading LLC | Institution | 58.699 | 0,06% | US$ 239,49k | 2026-03-31 |
| XTX Markets Limited | Institution | 57.190 | 0,06% | US$ 233,34k | 2026-03-31 |
| Bank of America Corporation | Institution | 56.525 | 0,06% | US$ 230,62k | 2026-03-31 |
| Bridgeway Capital Management, LLC | Institution | 53.500 | 0,05% | US$ 218,28k | 2026-03-31 |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
